First-in-human study of left ventricular remuscularization with induced pluripotent stem cell derived cardiomyocyte spheroids for severe ischemic heart failure patients: preliminary LAPiS study result
Event: Heart Failure 2024
Topic: Treatment
Session: Chronic heart failure - treatment 1
